These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 8125835)

  • 21. Ofloxacin versus vancomycin/polymyxin for prevention of infections in granulocytopenic patients.
    Winston DJ; Ho WG; Bruckner DA; Gale RP; Champlin RE
    Am J Med; 1990 Jan; 88(1):36-42. PubMed ID: 2153006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Experimental study of the antibacterial activity and chemotherapeutic efficacy of the novel glycopeptide eremomycin].
    Malikova IV
    Antibiot Khimioter; 1989 Jan; 34(1):52-6. PubMed ID: 2543344
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of mice with sepsis following irradiation and trauma with antibiotics and synthetic trehalose dicorynomycolate (S-TDCM).
    Madonna GS; Ledney GD; Moore MM; Elliott TB; Brook I
    J Trauma; 1991 Mar; 31(3):316-25. PubMed ID: 2002518
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The comparative efficacy and safety of teicoplanin and vancomycin.
    Wood MJ
    J Antimicrob Chemother; 1996 Feb; 37(2):209-22. PubMed ID: 8707731
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gram-positive infections in neutropenic patients: glycopeptide antibiotic choice.
    Menichetti F
    J Antimicrob Chemother; 1992 Apr; 29(4):461-3. PubMed ID: 1535070
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison of efficacy and safety of teicoplanin and vancomycin in children with antineoplastic therapy-associated febrile neutropenia and gram-positive bacteremia.
    Sidi V; Roilides E; Bibashi E; Gompakis N; Tsakiri A; Koliouskas D
    J Chemother; 2000 Aug; 12(4):326-31. PubMed ID: 10949982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of vancomycin, teicoplanin and fusidic acid as prophylactic agents in prevention of vascular graft infection: an experimental study in rat.
    Yasim A; Gul M; Atahan E; Ciragil P; Aral M; Ergun Y
    Eur J Vasc Endovasc Surg; 2006 Mar; 31(3):274-9. PubMed ID: 16360328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microbiological properties of teicoplanin.
    Greenwood D
    J Antimicrob Chemother; 1988 Jan; 21 Suppl A():1-13. PubMed ID: 2965119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quinolone therapy in the prevention of endogenous and exogenous infection after irradiation.
    Brook I; Ledney GD
    J Antimicrob Chemother; 1994 Apr; 33(4):777-84. PubMed ID: 8056696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Survival of irradiated mice treated with WR-151327, synthetic trehalose dicorynomycolate, or ofloxacin.
    Ledney GD; Elliott TB; Landauer MR; Vigneulle RM; Henderson PL; Harding RA; Tom SP
    Adv Space Res; 1994 Oct; 14(10):583-6. PubMed ID: 11539995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of a new glycopeptide antibiotic, teicoplanin, in the treatment of bacterial endocarditis.
    Webster A; Wilson AP; Williams AH; Treasure T; Grüneberg RN
    Postgrad Med J; 1987 Aug; 63(742):621-4. PubMed ID: 2962071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quinolone therapy in the prevention of mortality after irradiation.
    Brook I; Elliott TB
    Radiat Res; 1991 Oct; 128(1):100-3. PubMed ID: 1924719
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibiotics for gram-positive bacterial infections: vancomycin, teicoplanin, quinupristin/dalfopristin, oxazolidinones, daptomycin, dalbavancin, and telavancin.
    Nailor MD; Sobel JD
    Infect Dis Clin North Am; 2009 Dec; 23(4):965-82, ix. PubMed ID: 19909893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vascular graft infection by Staphylococcus aureus: efficacy of cefazolin, teicoplanin and vancomycin prophylaxis protocols in a rat model.
    Atahan E; Gul M; Ergun Y; Eroglu E
    Eur J Vasc Endovasc Surg; 2007 Aug; 34(2):182-7. PubMed ID: 17481929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Glycopeptide resistant enterococci. Occurrence, distribution, resistance transmission, significance].
    Klare I; Witte W
    Wien Klin Wochenschr; 1997 May; 109(9):293-300. PubMed ID: 9265387
    [No Abstract]   [Full Text] [Related]  

  • 36. Tolerability of teicoplanin in 117 hospitalized adults with previous vancomycin-induced fever, rash, or neutropenia: a retrospective chart review.
    Hung YP; Lee NY; Chang CM; Lee HC; Wu CJ; Chen PL; Lee CC; Chung CH; Ko WC
    Clin Ther; 2009 Sep; 31(9):1977-86. PubMed ID: 19843487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An audit of efficacy and toxicity of teicoplanin versus vancomycin in febrile neutropenia: is the different toxicity profile clinically relevant?
    Hahn-Ast C; Glasmacher A; Arns A; Mühling A; Orlopp K; Marklein G; Von Lilienfeld-Toal M
    Infection; 2008 Feb; 36(1):54-8. PubMed ID: 18193385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Teicoplanin. New treatment potentials for gram-positive infections in the hospital].
    Iakovlev SV
    Antibiot Khimioter; 1999; 44(2):3-7. PubMed ID: 10202550
    [No Abstract]   [Full Text] [Related]  

  • 39. [Adequate intrathecal diffusion of teicoplanin after failure of vancomycin, administered in continuous infusion in three cases of shunt associated meningitis].
    Jourdan C; Convert J; Peloux A; Boussaid O; Grando J; Tigaud S
    Pathol Biol (Paris); 1996 May; 44(5):389-92. PubMed ID: 8758482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The in vitro activity of ramoplanin (A-16686/MDL 62,198), vancomycin and teicoplanin against methicillin-susceptible and methicillin-resistant Staphylococcus spp.
    O'Hare MD; Felmingham D; Grüneberg RN
    Drugs Exp Clin Res; 1988; 14(10):617-9. PubMed ID: 2977587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.